Schlagwort: Dr Mark Manfredi
Precision oncology from the Rhineland
Cologne-based biotech start-up Disco Pharmaceuticals is taking a new approach to cancer therapy: using innovative cell-surface mapping to develop selective cancer therapeutics.
Malignant cells carry...